Isabel Emmerick to Lung Neoplasms
This is a "connection" page, showing publications Isabel Emmerick has written about Lung Neoplasms.
Connection Strength
2.939
-
Pires DC, Arueira Chaves L, Dantas Cardoso CH, Faria LV, Rodrigues Campos S, Sobreira da Silva MJ, Sequeira Valerio T, Rodrigues Campos M, Emmerick ICM. Effects of low dose computed tomography (LDCT) on lung cancer screening on incidence and mortality in regions with high tuberculosis prevalence: A systematic review. PLoS One. 2024; 19(9):e0308106.
Score: 0.611
-
Campos MR, Rodrigues JM, Marques AP, Faria LV, Valerio TS, Silva MJSD, Pires DC, Chaves LA, Cardoso CHD, Campos SR, Emmerick ICM. Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil. Rev Saude Publica. 2024; 58:18.
Score: 0.597
-
Emmerick ICM, Campos MR, Castanheira D, Muzy J, Marques A, Arueira Chaves L, Sobreira da Silva MJ. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines. JAMA Netw Open. 2023 12 01; 6(12):e2346994.
Score: 0.579
-
Emmerick ICM, Singh A, Powers M, Lou F, Lin P, Maxfield M, Uy K. Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis. Rev Saude Publica. 2021; 55:112.
Score: 0.505
-
Emmerick ICM, Uy K, Guiab K, Powers M, Lou F, Lin P, Maxfield M, Voland R, Varlotto J. Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis. J Cancer Policy. 2022 03; 31:100318.
Score: 0.505
-
Valerio TS, Emmerick ICM, Sobreira-da-Silva MJ. Factors associated with late-stage diagnosis and overall survival for lung cancer: An analysis of patients treated in a Brazilian hospital and a US-hospital from 2009 to 2019. Cancer Epidemiol. 2023 10; 86:102443.
Score: 0.142